Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women

被引:27
|
作者
Anastos, Kathryn [1 ,2 ]
Hoover, Donald R. [3 ,4 ]
Burk, Robert D. [5 ]
Cajigas, Antonio [6 ]
Shi, Qiuhu [7 ]
Singh, Diljeet K. [8 ]
Cohen, Mardge H. [9 ,10 ]
Mutimura, Eugene [11 ]
Sturgis, Charles [12 ]
Banzhaf, William C. [13 ]
Castle, Philip E. [14 ]
机构
[1] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
[3] Rutgers State Univ, Dept Stat, Piscataway, NJ USA
[4] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA
[5] Albert Einstein Coll Med, Dept Pediat, Div Genet, Bronx, NY 10467 USA
[6] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA
[7] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA
[8] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[9] John Stroger Hosp, Chicago, IL USA
[10] Rush Univ, Chicago, IL 60612 USA
[11] Womens Equ Access Care & Treatment, Kigali, Rwanda
[12] Providence Reg Med Ctr, Everett, WA USA
[13] Univ Chicago, Pritzker Sch Med, Evanston, IL USA
[14] NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA
来源
PLOS ONE | 2010年 / 5卷 / 10期
基金
美国国家卫生研究院;
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; NEOPLASIA; POPULATION; DIAGNOSIS; DNA; BIOPSY;
D O I
10.1371/journal.pone.0013525
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Although cervical cancer is an AIDS-defining condition, infection with human immunodeficiency virus (HIV) may only modestly increase the risk of cervical cancer. There is a paucity of information regarding factors that influence the natural history of human papillomavirus (HPV) in HIV-infected women. We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+). Methods: In 2005, 710 HIV+ Rwandan women >= 25 years enrolled in an observational cohort study; 476 (67%) tested HPV+. Each woman provided sociodemographic data, CD4 count, a cervical cytology specimen and cervicovaginal lavage (CVL), which was tested for >40 HPV genotypes by MY09/MY11 PCR assay. Logistic regression models calculated odds ratios (OR) and 95% confidence intervals (CI) of associations of potential risk factors for CIN3+ among HIV+/HPV+ women. Results: Of the 476 HIV+/HPV+ women 42 (8.8%) were diagnosed with CIN3+. Factors associated with CIN3+ included >= 7 (vs. 0-2) pregnancies, malarial infection in the previous six months (vs. never), and >= 7 (vs. 0-2) lifetime sexual partners. Compared to women infected by non-HPV16 carcinogenic HPV genotypes, HPV16 infection was positively associated and non-carcinogenic HPV infection was inversely associated with CIN3+. CD4 count was significantly associated with CIN3+ only in analyses of women with non-HPV16 carcinogenic HPV (OR = 0.62 per 100 cells/mm(3), CI = 0.40-0.97). Conclusions: In this HIV+/HPV+ population, lower CD4 was significantly associated with CIN3+ only in women infected with carcinogenic non-HPV16. We found a trend for higher risk of CIN3+ in HIV+ women reporting recent malarial infection; this association should be investigated in a larger group of HIV+/HPV+ women.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women
    Lehtovirta, Paeivi
    Paavonen, Jorma
    Heikinheimo, Oskari
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (01) : 37 - 41
  • [32] Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women
    Chen, Xiaojun
    Wei, Sun
    Ma, Hongxia
    Jin, Guangfu
    Hu, Zhibin
    Han Suping
    Li, Dake
    Hang, Dong
    Wu, Xiaohua
    Li, Ni
    CANCER MEDICINE, 2019, 8 (10): : 4845 - 4851
  • [33] Screening for cervical carcinoma in HIV-infected women: Analysis of main risk factors for cervical cytologic abnormalities
    Sansone, Matilde
    Saccone, Gabriele
    Migliucci, Annalisa
    Saviano, Rosa
    Capone, Angela
    Maruotti, Giuseppe Maria
    Bruzzese, Dario
    Martinelli, Pasquale
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (02) : 352 - 357
  • [34] p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
    Wentzensen, Nicolas
    Fetterman, Barbara
    Castle, Philip E.
    Schiffman, Mark
    Wood, Shannon N.
    Stiemerling, Eric
    Tokugawa, Diane
    Bodelon, Clara
    Poitras, Nancy
    Lorey, Thomas
    Kinney, Walter
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (12):
  • [35] Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women
    Santos Filho, M. V. C.
    Gurgel, A. P. A. D.
    Lobo, C. D. P.
    Freitas, A. C. F.
    Silva-Neto, J. C.
    Silva, L. A. F.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02):
  • [36] Perinatal risk factors for HIV-infected pregnant women
    Posokhova, S
    XIV INTERNATIONAL AIDS CONFERENCE: INTERVENTIONS AND PROGRAM IMPLEMENTATION, 2002, : 131 - 134
  • [37] LSF EXPRESSION IN HPV-POSITIVE CERVICAL CANCER AND ENDOMETRIAL CANCER
    Kwasniewski, W.
    Broniarczyk, J.
    Kotarski, J.
    Gozdzicka-Jozefiak, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1969 - 1969
  • [38] Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women
    Wyatt, Christina M.
    Shi, Qiuhu
    Novak, James E.
    Hoover, Donald R.
    Szczech, Lynda
    Mugabo, Jules Semahore
    Binagwaho, Agnes
    Cohen, Mardge
    Mutimura, Eugene
    Anastos, Kathryn
    PLOS ONE, 2011, 6 (03):
  • [39] The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer
    Yi Liu
    Hejing Liu
    Bo Sheng
    Shuya Pan
    Zhi-wei Wang
    Xueqiong Zhu
    Apoptosis, 2022, 27 : 685 - 696
  • [40] The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer
    Liu, Yi
    Liu, Hejing
    Sheng, Bo
    Pan, Shuya
    Wang, Zhi-wei
    Zhu, Xueqiong
    APOPTOSIS, 2022, 27 (9-10) : 685 - 696